chemicals
Commented by Nico Popp on July 17th, 2023 | 07:55 CEST
The hour of the problem solvers: BASF, BYD, dynaCERT
The transformation of industry is not proceeding smoothly. The best example is the recent profit warning from the chemical group BASF. Earlier, Lanxess and the Swiss company Clariant also revised their forecasts. The reason: The economic recovery in the second half of the year is likely to be slower than previously assumed. When the global economy falters, chemical companies are among the first to feel the effects - they produce many important basic materials and are linked to many other industries. Although BASF already sees demand for basic chemicals at a low level that is not expected to decline further, there are no signs of any recovery momentum either.
Read
Commented by Fabian Lorenz on July 14th, 2023 | 07:50 CEST
Bulls at the controls: Nel, Barrick Gold, Viva Gold! What about BASF?
Low inflation in the US has given new impetus to the bulls. Not only are growth stocks benefiting from the hope that the interest rate cycle is coming to an end, but also gold. Thus, the gold price reacted on Wednesday by jumping to over USD 1,960 per troy ounce. Top-tier gold stocks such as Barrick also responded positively. Exploration companies have significant catch-up potential, including Viva Gold. The Company is favorably valued and has again reported positive drill results. The fact that the interest rate cycle is nearing its end is also evident in the chemical industry. Most recently, BASF issued a warning, and there are sell recommendations. On the other hand, there are buy recommendations for the Nel share.
Read
Commented by Stefan Feulner on July 14th, 2023 | 07:30 CEST
Plug Power, First Phosphate, BASF - Turnaround in sight
After a sharp correction that lasted for months, companies in the renewable energy sector are forming a sustainable bottom. In recent trading days, the prices of water, wind and solar shares have moved significantly away from their lows. From a fundamental perspective, the future appears rosy, which could present a favourable long-term entry opportunity.
Read
Commented by Nico Popp on June 22nd, 2023 | 09:05 CEST
Isolation and e-car crash - A new China shock for markets? BASF, NIO, Power Nickel
It was a profit warning with a signal effect: Lanxess shares plunged on Tuesday after a gloomy outlook. The BASF share also came under pressure as a result. Once again, developments around China are causing concern. While the major economies are increasingly isolating themselves and relying on autarky and protectionism, the collateral damage is increasing. But there are also profiteers. We shed light on the opportunities and risks.
Read
Commented by Stefan Feulner on June 21st, 2023 | 07:20 CEST
Lanxess, Smartbroker, Helma Eigenheimbau - Great opportunities in uncertain times
The stock market is still defying negative omens such as recession, the strict monetary policy of the central banks and escalating geopolitical risks. Just a few days ago, for example, the German leading index DAX recorded a new all-time high. However, the negative voices concerning significant global stock market setbacks are increasing. Nevertheless, some companies have the potential to significantly outperform the market due to special situations.
Read
Commented by Fabian Lorenz on June 7th, 2023 | 08:00 CEST
Commodity shares with price potential: Bayer, K+S, and Almonty Industries in the analyst check
There are no signs of a deep recession in the US at the moment, which is positive for commodity prices and the corresponding companies. What do analysts say? They see a price potential of over 170% for tungsten producer Almonty Industries. With the commissioning of the flagship mine in South Korea, revenues and profits should increase strongly from 2024. After K+S earned brilliantly last year, there is a lack of positive impulses this year. Several analysts have spoken out. Can the DAX-listed company make gains again? At Bayer, the euphoria surrounding the change in the board of directors has faded, and the share price is almost back to where it was at the beginning of the year. But analysts see significant upside potential.
Read
Commented by Nico Popp on May 18th, 2023 | 09:30 CEST
Climate protection as an investment: BASF, Commerzbank, GoviEX Uranium
Fewer CO2 emissions, more climate protection. Every DAX-listed company is committed to more sustainability in some form or another. But what is the truth of these promises? And are the supposed climate shares a sustainable investment at all? We do the check and take a detailed look at three exciting stocks from different sectors and regions.
Read
Commented by Fabian Lorenz on May 4th, 2023 | 08:10 CEST
Buy or sell? TUI, BASF and Defence Therapeutics
BASF share a buy or sell? Analyst opinions on the chemical giant diverge widely. The DAX-listed company has just reported quarterly figures, but it did not provide clarity about the prospects. However, some speculate on a forecast increase. Analysts have not commented on TUI for quite some time. After the turbulence surrounding the capital increase, new impulses are being sought, perhaps through a deal with the German government? There is plenty of impetus for rising prices at Defence Therapeutics. The biotech high-flyer of the past months is increasingly positioning itself as a partner to BioNTech, Moderna and Co - and perhaps even a takeover candidate.
Read
Commented by Nico Popp on March 29th, 2023 | 08:15 CEST
Market failure! Highs and lows at BASF, Myriad Uranium, Vonovia
We all know efficient markets from the textbook. There, buyers and sellers always come together - and in the end, there is no apple left over. In reality, markets are highly complex and are sometimes dependent on external factors that can change everything overnight. Today we look at BASF's business in China, the real estate market and the emerging market for uranium.
Read
Commented by Fabian Lorenz on March 8th, 2023 | 16:22 CET
Nel share slumps, a 60% chance with Bayer, Almonty Industries and BASF
The Nel share was one of the big daily losers yesterday. As a result, the upward trend has finally been broken, and analysts' opinions differ widely. Berenberg sees the BASF share as a hold after the publication of the quarterly figures. The price target is EUR 55. The figures are in line with expectations. However, the end of share buybacks and concerns about future competitiveness weigh on the stock. By contrast, analysts see up to 60% upside potential for Bayer. Almonty Industries is benefiting from the boom in electromobility and also defense spending. As the leading tungsten producer outside China, analysts suspect it could soon come to a bidding war.
Read